The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...
Many patients with scarring alopecia say they feel more confident in their care when they see a dermatologist who is a hair ...
Hayley Knollman, MD, explains how ctDNA and genomic testing impact ER-positive metastatic breast cancer care, guiding ...
FDA is encouraging supplemental NDAs for TRT to treat low libido in idiopathic hypogonadism, reflecting preliminary ...
With oncology now the largest cost center for health plans, experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...
High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...
At AMCP 2026, Daryl Pritchard, PhD, highlighted fragmentation, evidence gaps, and decision support needs limiting precision ...
The July 2026 advisory review could reopen compounding pathways for peptides previously curtailed in 2023 over immunogenicity ...
Metabolic disease is reshaping care delivery and costs, with experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...
Kelsea Aragon, PharmD, highlights the role of long-acting HIV therapies like lenacapavir and cabotegravir in improving ...
The end of 2025 saw the expiration of the enhanced premium subsidies under the Affordable Care Act (ACA) after Congress was ...
Rising Specialty Drug Costs and Co-Pay Models Raise Access Concerns: Patty Taddei-Allen, PharmD, MBA
In addition to the models, Taddei-Allen also pointed out the overall shift in employer plan drug costs, shifting more of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results